MedPath

Altair Therapeutics, Inc.

Altair Therapeutics, Inc. logo
🇺🇸United States
Ownership
Private
Established
2007-01-01
Employees
1
Market Cap
-
Website
http://www.altairthera.com

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma

Phase 2
Completed
Conditions
Asthma
Interventions
Drug: Physiologic saline solution
First Posted Date
2009-07-17
Last Posted Date
2010-07-23
Lead Sponsor
Altair Therapeutics, Inc.
Target Recruit Count
30
Registration Number
NCT00941577

A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma

Phase 1
Completed
Conditions
Asthma
Interventions
Drug: Physiologic saline solution
First Posted Date
2008-04-15
Last Posted Date
2009-06-25
Lead Sponsor
Altair Therapeutics, Inc.
Target Recruit Count
80
Registration Number
NCT00658749
Locations
🇺🇸

Contract Research Organization (CRO) appointed by Altair Therapeutics--Altair's offices are in:, San Diego, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.